Optimal Supportive Care With Selinexor Improves Outcomes in Patients With Relapsed/Refractory Multiple Myeloma
- Ajai Chari
- , Erika Florendo
- , Ines Stefania Mancia
- , Hearn Cho
- , Deepu Madduri
- , Samir Parekh
- , Josh Richter
- , Amishi Dhadwal
- , Joanne Thomas
- , Grace Jiang
- , Alessandro Lagana
- , Sherry Bhalla
- , Sundar Jagannath
- Icahn School of Medicine at Mount Sinai
- Medicine
- Medicine - Hematology and Medical Oncology
- Graduate School of Biomedical Sciences
- Marc and Jennifer Lipschultz Precision Immunology Institute
- Mount Sinai Academy of Physician-Scientists
- Cancer Clinical Investigation
- Icahn Genomics Institute
- Mount Sinai Tisch Cancer Center
- Friedman Brain Institute
- Institute for Next Generation Healthcare
- Oncological Sciences
Research output: Contribution to journal › Article › peer-review
10
Scopus
citations